These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 6252629)
1. [Should the menopause be treated ? When and how? (author's transl)]. Soria R Sem Hop; 1980 Sep 18-25; 56(33-36):1374-9. PubMed ID: 6252629 [TBL] [Abstract][Full Text] [Related]
2. Cancer and the use of estrogens. Gambrell RD Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032 [TBL] [Abstract][Full Text] [Related]
3. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [TBL] [Abstract][Full Text] [Related]
4. Re-evaluating the role of progestogen therapy after the menopause. Henderson BE; Ross RK; Lobo RA; Pike MC; Mack TM Fertil Steril; 1988 May; 49(5 Suppl 2):9S-15S. PubMed ID: 3360188 [TBL] [Abstract][Full Text] [Related]
5. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Gambrell RD; Maier RC; Sanders BI Obstet Gynecol; 1983 Oct; 62(4):435-43. PubMed ID: 6888821 [TBL] [Abstract][Full Text] [Related]
6. Sex steroids and cancer. Gambrell RD Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519 [TBL] [Abstract][Full Text] [Related]
7. Cancer in the older woman: diagnosis and prevention. Gambrell RD Geriatrics; 1988 Sep; 43(9):27-32, 35-6. PubMed ID: 3044928 [TBL] [Abstract][Full Text] [Related]
9. Clinical use of progestins in the menopausal patient: dosage and duration. Gambrell RD J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446 [TBL] [Abstract][Full Text] [Related]
10. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
11. [Estrogens and progestins in hormone replacement therapy in menopause]. La Vecchia C Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854 [TBL] [Abstract][Full Text] [Related]
13. Progestogen use in women approaching the menopause and breast cancer risk. Campagnoli C; Ambroggio S; Lotano MR; Peris C Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958 [TBL] [Abstract][Full Text] [Related]
15. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
16. Estrogen replacement therapy: current thinking and practice. DeFazio J; Speroff L Geriatrics; 1985 Nov; 40(11):32-7, 40-3, 47-8. PubMed ID: 4054632 [TBL] [Abstract][Full Text] [Related]
17. [Estrogens and postmenopause (author's transl)]. Rezaković-Musić D Lijec Vjesn; 1981; 103(2-3):97-104. PubMed ID: 7031394 [No Abstract] [Full Text] [Related]
18. Options for hormone therapy in women who have had a hysterectomy. Haney AF; Wild RA Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150 [TBL] [Abstract][Full Text] [Related]
19. Estrogen and the menopause. Yen SS Am Fam Physician; 1977 Jul; 16(1):87-91. PubMed ID: 878981 [TBL] [Abstract][Full Text] [Related]